Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study

Sanoculis

Status: Enrolling

Conditions: Open Angle Glaucoma

Treatments: Device: Inferonasal Minimally Invasive Micro Sclerostomy

Study type: Observational

Funder types: Industry

Identifiers

NCT06577857

MMS-EEU-8

Details and patient eligibility

About

A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).

Enrollment: 53 estimated patients

Sex: All

Ages: 40 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment

Trial design

53 participants in 1 patient group

Inferonasal MIMS Surgery Cohort

Description:

Cohort that includes subjects that have undergone the MIMS® inferonasal surgery.

Treatment:

Device: Inferonasal Minimally Invasive Micro Sclerostomy